Translate

Πέμπτη 12 Δεκεμβρίου 2019

Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype

Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype:
British Journal of Cancer, Published online: 13 December 2019; doi:10.1038/s41416-019-0685-1
Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype

Abstract
Background
The incidence of oesophageal adenocarcinoma is increasing globally. Barrett’s oesophagus (BO) is a pre-malignant condition with no biomarker to risk stratify those at highest risk of dysplasia and malignant transformation.

Methods
Subcellular epithelial protein (HMGB1, p53, RUNX3) expression, alongside expression of CD20, CD4, CD8 and Foxp3 to characterise stromal B lymphocyte, and helper, cytotoxic and regulatory T-lymphocyte cell infiltrate, respectively, was assessed by immunohistochemistry in 218 human tissue samples including normal oesophageal/gastric biopsies (n = 39), BO (non-dysplasia, dysplasia, non-dysplastic background from progressors to dysplasia or cancer, n = 121) and oesophageal adenocarcinoma (n = 58).

Results
There is a dynamic subcellular epithelial expression of HMGB1 (loss of nuclear, emergence of cytoplasmic), associated with epithelial p53 expression and differential immune cell phenotype in oesophageal neoplastic progression. We identify a protein signature and lymphocyte infiltrate in non-dysplastic BO when progressive disease (dysplasia or adenocarcinoma) is present but not histologically represented in the biopsied field. There is a dynamic stromal lymphocytic infiltrate in oesophageal neoplastic progression.

Conclusions
This data reveals novel insights into the microenvironment of BO and progression towards cancer and identifies a novel high-risk biomarker of disease progression to aid surveillance strategies to identify early progression and impact future incidence of oesophageal cancer.

1 σχόλιο:

  1. Chemicals used in industries gives me Leukemia and it's all started when I wanted to get off my job to get another job that when I got diagnose, at that very point I was so scared to die because it has infected my blood cells also I was prescribed drugs like Cyclophosphamide,Busulfan,Bosutinib,Cytarabine, Cytosar-U (Cytarabine),Dasatinib in all that was just to keep me waiting for my dying day. I got inspired by what I read from a lady on blog spot on how Dr God hands cure her HIV/Aids with herbal medicine then they were lettered below that says he can cure Cancer so I pick his contact on the testimony she wrote then I emailed Dr God hands hopefully he replied swiftly to my mail then I purchased his Herbal medicine also it was shipped to me here in Texas, I went to pick it at post office so he instructs me on how the treatment will take me three weeks to cure my Leukemia Disease, Joyfully I was cured by this Dr God hands Herbal Medicine.
    I will advise you too to give a try to Dr God hands Herbal Medicine with the following diseases that he can help you cure permanently such diabetes, Herpes, HIV/Aids, Bladder Cancer, Breast Cancer,Parkinson's disease,Lung Cancer, Breast Cancer, Colo-Rectal Cancer, Blood Cancer, Prostate Cancer,Arthritis,Fibromyalgia,Adrenocortical carcinoma. Asthma, Cold, Glaucoma, Cardiovascular disease, Lung disease, Enlarged prostate, Alzheimer's disease, Dementia, Vaginal Cancer, Kidney Cancer, Lung Cancer, Skin Cancer, Uterine Cancer, Prostate Cancer, Colo_Rectal Cancer, Leukemia Cancer, Hepatitis, Brain Tumors, Love Spell, Infertility, Hpv. GoodLuck, XoXo****Dr Owo Ibuku Also known as Doctor God hands Contact Information:::Email (doctorgodhands@gmail.com) WhatsApp-(+2349057214220)

    ΑπάντησηΔιαγραφή

Αρχειοθήκη ιστολογίου

Translate